Hyderabad-based IIL get DCGI nod for Measles-Rubella vaccine
[ad_1] (Photo: ANI) Hyderabad: The vaccine makers based in Hyderabad, Indian Immunologicals Limited (IIL), have received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (TSDCA) for manufacturing its Measles-Rubella (MR) Vaccine. As an outcome of the Indo-Vietnam partnership, the product has been in the works for more than … Read more